Publication Name	World Journal of Gastrointestinal Oncology
Manuscript ID	79831
Country	China

Received	2022-09-08 13:47
Peer-Review Started	2022-09-08 13:51
To Make the First Decision
Return for Revision	2022-11-12 02:39
Revised	2022-11-23 08:14
Second Decision	2023-01-05 03:42
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2023-01-05 19:42
Articles in Press	2023-01-05 19:42
Publication Fee Transferred
Edit the Manuscript by Language Editor	2022-12-15 01:39
Typeset the Manuscript	2023-01-18 09:13
Publish the Manuscript Online	2023-02-15 00:44

ISSN	1948-5204 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Basic Study
Article Title	Cancerous inhibitor of protein phosphatase 2A enhances chemoresistance of gastric cancer cells to oxaliplatin
Manuscript Source	Unsolicited Manuscript
All Author List	Yong-Xun Zhao, Li-Bin Ma, Ze Yang, Fang Wang, Hui-Ying Wang and Jia-Yao Dang
Funding Agency and Grant Number	Funding Agency Grant Number Natural Science Foundation of Gansu Province 17JR5RA272 the Research Fund Project of The First Hospital of Lanzhou University ldyyyn2020-98 the Research Fund Project of The First Hospital of Lanzhou University ldyyyn2021-120 the Research Fund Project of The First Hospital of Lanzhou University ldyyyn2021-30
Corresponding Author	Yong-Xun Zhao, PhD, Surgeon, The Seventh Department of General Surgery, The First Hospital of Lanzhou University, No. 1 Donggang West Road, 730000, Lanzhou 730000, Gansu Province, China. yongxunzh@163.com
Key Words	Cancerous inhibitor of protein phosphatase 2A; Gastric cancer; Oxaliplatin; Chemoresistance; Akt
Core Tip	Zhao YX, Ma LB, Yang Z, Wang F, Wang HY, Dang JY. Cancerous inhibitor of protein phosphatase 2A enhances chemoresistance of gastric cancer cells to oxaliplatin. World J Gastrointest Oncol 2022; In press
Publish Date	2023-02-15 00:44
Citation	Zhao YX, Ma LB, Yang Z, Wang F, Wang HY, Dang JY. Cancerous inhibitor of protein phosphatase 2A enhances chemoresistance of gastric cancer cells to oxaliplatin. World J Gastrointest Oncol 2023; 15(2): 286-302
URL	https://www.wjgnet.com/1948-5204/full/v15/i2/286.htm
DOI	https://dx.doi.org/10.4251/wjgo.v15.i2.286

Full Article (PDF)	WJGO-15-286.pdf
Full Article (Word)	WJGO-15-286.docx
Manuscript File	79831_Auto_Edited-LM.docx
Answering Reviewers	79831-Answering reviewers.pdf
Audio Core Tip	79831-Audio core tip.mp3
Biostatistics Review Certificate	79831-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form	79831-Conflict-of-interest statement.pdf
Copyright License Agreement	79831-Copyright license agreement.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s)	79831-Grant application form(s).pdf
Institutional Review Board Approval Form or Document	79831-Institutional review board statement.pdf
Non-Native Speakers of English Editing Certificate	79831-Language certificate.pdf
Peer-review Report	79831-Peer-review(s).pdf
Scientific Misconduct Check	79831-Bing-Liu GL-2.png
Scientific Editor Work List	79831-Scientific editor work list.pdf